CAS 1391052-17-7

Rasagiline-13C3

Kontrolliertes Produkt

CAS: 1391052-17-7

Rasagiline-13C3 is a medicinal product that belongs to the group of inhibitors. It has been shown to have potent anticancer properties and can be used for the treatment of tumors in humans. Rasagiline-13C3 works by inhibiting the activity of kinases, which are enzymes that play a crucial role in cancer cell growth and division. This drug is an analog of polysaccharides found in Chinese medicine, which have been traditionally used for their medicinal properties. Rasagiline-13C3 induces apoptosis, a process of programmed cell death, in cancer cells and prevents their proliferation. This drug has also been detected in urine samples after administration, indicating its potential use as a diagnostic tool for cancer detection.

Formel: C₁₂H₁₃N

Reinheit: Min. 95%

Molekulargewicht: 174.22 g/mol

Ref: 3D-RFC05217